Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group.

Abstract

AIMS To review indications for surgery and outcomes of patients with complex locally advanced pelvic malignancies treated by a multidisciplinary Pelvic Oncology Group. PATIENTS AND METHODS Between March 1992 and March 2003, 130 patients were jointly assessed in a monthly clinic involving urological, gynaecological, colorectal and plastic surgeons, an oncologist and nurse specialists. Seventy-six patients proceeded to exenterative surgery. RESULTS Rectal carcinoma and gynaecological cancers were the two most common indications for surgery. Median follow-up was 14 months (range 1-120 months). There were no deaths within 30 days of surgery. The morbidity rate was 28%. Predicted 5 years survival was 53% in cases with clear histological margins and no lymph node metastasis. CONCLUSION With careful patient selection and multi specialty care pelvic exenteration is a safe and effective option in the treatment of complex locally advanced pelvic malignancy.

020402011201220132014201520162017
Citations per Year

67 Citations

Semantic Scholar estimates that this publication has 67 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Nguyen2005ExenterativePS, title={Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group.}, author={Dai Nguyen and Alan D. McGregor and Omar Freites and Nicholas D Carr and John Beynon and Awatef M el-Sharkawi and Marsha G Lucas}, journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology}, year={2005}, volume={31 10}, pages={1180-4} }